Comment
. 2007 Mar 15;195(6):913-4; author reply 916-7.
doi: 10.1086/507045.
Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women
- PMID: 17299723
- DOI: 10.1086/507045
Item in Clipboard
Comment
Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women
J Infect Dis.
.
No abstract available
Comment on
-
Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?J Infect Dis. 2006 May 1;193(9):1195-201. doi: 10.1086/503045. Epub 2006 Mar 28. J Infect Dis. 2006. PMID: 16586354
Similar articles
-
Protease inhibitor-associated increased risk of preterm delivery is an immunological complication of therapy.J Infect Dis. 2007 Mar 15;195(6):914-6; author reply 916-7. doi: 10.1086/511983. J Infect Dis. 2007. PMID: 17299724 No abstract available.
-
Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?J Infect Dis. 2006 May 1;193(9):1195-201. doi: 10.1086/503045. Epub 2006 Mar 28. J Infect Dis. 2006. PMID: 16586354
-
Protease inhibitor use during pregnancy: is there an obstetrical risk?J Infect Dis. 2006 May 1;193(9):1191-4. doi: 10.1086/503049. Epub 2006 Apr 3. J Infect Dis. 2006. PMID: 16586353 No abstract available.
-
[Hepatitis C virus infection and pregnancy].Gastroenterol Hepatol. 2000 Dec;23(10):480-2. Gastroenterol Hepatol. 2000. PMID: 11149224 Review. Spanish. No abstract available.
-
Update on antiretroviral therapy.Arch Dis Child. 2009 Jan;94(1):70-4. doi: 10.1136/adc.2007.128744. Epub 2008 Oct 6. Arch Dis Child. 2009. PMID: 18838416 Review.
Cited by
-
Perinatal Exposure to HIV Infection: The Experience of Craiova Regional Centre, Romania.Healthcare (Basel). 2022 Feb 6;10(2):308. doi: 10.3390/healthcare10020308. Healthcare (Basel). 2022. PMID: 35206923 Free PMC article.
-
Risk factors of HIV-1 vertical transmission (VT) and the influence of antiretroviral therapy (ART) in pregnancy outcome.Rev Inst Med Trop Sao Paulo. 2014 Mar-Apr;56(2):133-8. doi: 10.1590/S0036-46652014000200008. Rev Inst Med Trop Sao Paulo. 2014. PMID: 24626415 Free PMC article.
-
Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa.BMC Pregnancy Childbirth. 2016 Feb 11;16:35. doi: 10.1186/s12884-016-0821-3. BMC Pregnancy Childbirth. 2016. PMID: 26867536 Free PMC article.
-
Low Prolactin and High 20-α-Hydroxysteroid Dehydrogenase Levels Contribute to Lower Progesterone Levels in HIV-Infected Pregnant Women Exposed to Protease Inhibitor-Based Combination Antiretroviral Therapy.J Infect Dis. 2016 May 15;213(10):1532-40. doi: 10.1093/infdis/jiw004. Epub 2016 Jan 5. J Infect Dis. 2016. PMID: 26740274 Free PMC article.
-
Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):128-35. doi: 10.1097/QAI.0000000000000281. J Acquir Immune Defic Syndr. 2014. PMID: 25072616 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
